Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joanne T. Beck currently holds 14,100 shares of Orchard Therapeutics plc (ORTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joanne T. Beck has been a net neutral trader of ORTX stock. They have purchased $0 and sold $0 worth of shares.
Joanne T. Beck's most recent insider trade was on Jun 5, 2024, when they sold 14,100 shares at $0.00 per share.
Joanne T. Beck serves as Executive at Orchard Therapeutics plc (ORTX). They have executed 4 insider transactions totaling $0 over their tenure at the company.
Joanne T. Beck holds the position of Executive at Orchard Therapeutics plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Joanne T. Beck has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Joanne T. Beck was on Jun 5, 2024, when they purchased $0 worth of ATXS shares. This transaction involved 14,100 shares at N/A per share.
Joanne T. Beck currently owns 14,100 shares of Orchard Therapeutics plc (ORTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joanne T. Beck's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joanne T. Beck has 4 Form 4 filings on record as an insider at Orchard Therapeutics plc.
Set alerts for Joanne T. Beck and 40,000+ other insiders.